» Articles » PMID: 37392321

Recurrent Reversible Cerebral Vasoconstriction Syndrome and Antiphospholipid Syndrome

Overview
Publisher Springer
Specialty Neurology
Date 2023 Jul 1
PMID 37392321
Authors
Affiliations
Soon will be listed here.
References
1.
Dingli D, Tan T, Kumar S, Buadi F, Dispenzieri A, Hayman S . Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis. Neurology. 2010; 74(11):913-8. DOI: 10.1212/WNL.0b013e3181d55f4d. View

2.
Boitet R, de Gaalon S, Duflos C, Marin G, Mawet J, Burcin C . Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome. Stroke. 2019; 51(2):670-673. DOI: 10.1161/STROKEAHA.119.027703. View

3.
Chen S, Fuh J, Lirng J, Wang Y, Wang S . Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study. Neurology. 2015; 84(15):1552-8. DOI: 10.1212/WNL.0000000000001473. View

4.
Gupta S, Zivadinov R, Ramasamy D, Ambrus Jr J . Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clin Rheumatol. 2013; 33(12):1829-33. DOI: 10.1007/s10067-013-2434-9. View

5.
Ducros A . Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012; 11(10):906-17. DOI: 10.1016/S1474-4422(12)70135-7. View